跳至主要内容
临床试验/NCT01591382
NCT01591382已完成4 期

Hydromorphone PCA or Hydromorphone PCA With Ketamine for Acute Postoperative Pain Relief in Opioid-Dependent Chronic Pain Patients

Brigham and Women's Hospital1 个研究点 分布在 1 个国家目标入组 64 人开始时间: 2008年9月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
64
试验地点
1
主要终点
Average Postoperative Pain Score

研究概览

简要总结

Patients who are dependent on opioids often have poor pain relief after major surgery. This study tests the hypothesis that adding intravenous ketamine to a postoperative regimen of intravenous opioids for postoperative pain will improve pain relief in this subset of patients.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Single Group
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Chronic pain > 6 months
  • Long term use of opioids
  • Major surgery

排除标准

  • Use of regional anesthetic techniques
  • No need for intravenous (IV) patient controlled analgesia (PCA) after surgery

研究组 & 干预措施

Ketamine

Active Comparator

Participants received postoperative hydromorphone patient-controlled analgesia (PCA) and continuous ketamine (0.2 mg/kg/hour). Ketamine is being compared to the use of placebo, in addition to intravenous opioids, for postop pain control in opioid dependent patients who undergo major surgery.

干预措施: Ketamine (Drug)

Ketamine

Active Comparator

Participants received postoperative hydromorphone patient-controlled analgesia (PCA) and continuous ketamine (0.2 mg/kg/hour). Ketamine is being compared to the use of placebo, in addition to intravenous opioids, for postop pain control in opioid dependent patients who undergo major surgery.

干预措施: Hydromorphone PCA (Drug)

Placebo

Placebo Comparator

Participants received postoperative hydromorphone PCA and continuous ketamine-matching placebo (infusion of saline).

干预措施: Placebo (Drug)

Placebo

Placebo Comparator

Participants received postoperative hydromorphone PCA and continuous ketamine-matching placebo (infusion of saline).

干预措施: Hydromorphone PCA (Drug)

结局指标

主要结局

Average Postoperative Pain Score

时间窗: Participants were followed for the duration of hospital stay, an average of approximately 3 days.

Postoperative pain scores were collected once per day during morning rounds for the preceding 24 hours. Participant were asked to provide pain scores for "worst," "average," and "least" pain using the 11-point Numerical Rating Scale (NRS), where 0 represents the absence of pain and 10 is worst possible pain. The average postoperative pain score for each treatment arm is reported.

次要结局

  • 24-Hour Postoperative Opioid Use(For 24 hours following surgery)
  • Worst Postoperative Pain Score(Participants were followed for the duration of hospital stay, an average of approximately 3 days.)
  • Least Postoperative Pain Score(Participants were followed for the duration of hospital stay, an average of approximately 3 days.)
  • Number of Participants With Treatment Related Adverse Events (AEs)(Participants were followed for the duration of hospital stay, an average of approximately 3 days.)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Srdjan Nedeljkovic

Staff, Pain Management Center

Brigham and Women's Hospital

研究点 (1)

Loading locations...

相似试验